Exploring the Impact of Semaglutide on Cognitive Function and Anxiety-Related Behaviors in a Murine Model of Alzheimer’s Disease
The findings of this pilot study suggest that SEM may play a dual role in managing AD by improving glycemic control and potentially enhancing cognitive function. As the landscape of AD treatment evolves, the comprehensive approach of utilizing SEM could pave the way for innovative interventions targeting the complex interplay of metabolic and cognitive dysfunctions in this challenging neurodegenerative disorder.
Authors
- Andreea-Daniela Meca (ORCID: https://orcid.org/0000-0002-6890-049X)
- Mária Bogdán (ORCID: https://orcid.org/0000-0001-8089-1787)
- Liliana Mititelu-Tarțău (ORCID: https://orcid.org/0000-0001-7983-3811)
- Ianis Kevyn Ştefan Boboc (ORCID: https://orcid.org/0000-0002-8516-9766)
- Petrica-Daniel Dumitrelea
Institutions
- University of Medicine and Pharmacy of Craiova (RO)
- Grigore T. Popa University of Medicine and Pharmacy (RO)
Publication Details
- Journal
- Biomedicines
- Published
- 2024-11-25
- DOI
- https://doi.org/10.3390/biomedicines12122689
- Citations
- 4
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.31